BAYLOR COLLEGE OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE)
Phase 1
Completed
- Conditions
- Adenovirus InfectionEpstein-Barr Virus InfectionsCytomegalovirus InfectionsStem Cell Transplant
- Interventions
- Biological: Multi-virus Specific T cells
- First Posted Date
- 2010-02-18
- Last Posted Date
- 2014-09-04
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 10
- Registration Number
- NCT01070797
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
NAC as a Potential Treatment for Methamphetamine Dependence
Phase 1
Completed
- Conditions
- Methamphetamine AbuseMethamphetamine DependenceSubstance Abuse
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-02-05
- Last Posted Date
- 2012-07-27
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 10
- Registration Number
- NCT01063205
- Locations
- 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States
The Effects of Doxazosin on the Cardiovascular and Subjective Effects of Cocaine
Phase 1
Completed
- Conditions
- Cocaine AddictionCocaine AbuseCocaine DependenceSubstance Abuse
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-02-04
- Last Posted Date
- 2012-07-27
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 13
- Registration Number
- NCT01062945
- Locations
- 🇺🇸
Michael Debakey VA Medical Center, Houston, Texas, United States
An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence
Phase 1
Completed
- Conditions
- Methamphetamine AbuseMethamphetamine DependenceSubstance Abuse
- Interventions
- First Posted Date
- 2010-02-04
- Last Posted Date
- 2022-04-26
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 80
- Registration Number
- NCT01062451
- Locations
- 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States
Investigation of Cycloserine as a Smoking Cessation Treatment
- First Posted Date
- 2010-02-04
- Last Posted Date
- 2012-07-27
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 34
- Registration Number
- NCT01062932
- Locations
- 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States
Functional Neuroimaging of Cortical Plasticity in the Human Visual System
Withdrawn
- Conditions
- StrokeVisionBlindness
- First Posted Date
- 2010-02-04
- Last Posted Date
- 2022-04-11
- Lead Sponsor
- Baylor College of Medicine
- Registration Number
- NCT01062672
- Locations
- 🇩🇪
Max Planck Institute for Biological Cybernetics, Tuebingen, Germany
🇺🇸Baylor College of Medicine, Houston, Texas, United States
Dexmedetomidine in Pediatric Tonsillectomy
Phase 4
Completed
- Conditions
- Pediatric AdenotonsillectomyPost Operative Analgesia
- Interventions
- First Posted Date
- 2010-01-27
- Last Posted Date
- 2021-07-27
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 109
- Registration Number
- NCT01057381
- Locations
- 🇺🇸
Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, United States
Pain and Anxiety Management With Oral Narcotic for Pediatric Suture Repair
Not Applicable
Completed
- Conditions
- ChildrenLacerationsProceduresChildPain
- Interventions
- Drug: hydrocodone/acetaminophen
- First Posted Date
- 2010-01-21
- Last Posted Date
- 2021-08-25
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 85
- Registration Number
- NCT01053637
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?
- First Posted Date
- 2009-12-30
- Last Posted Date
- 2016-06-22
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 25
- Registration Number
- NCT01040819
- Locations
- 🇺🇸
Baylor Clinics, Houston, Texas, United States
🇺🇸Baylor College of Medicine, HOuston, Texas, United States
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
Phase 1
Completed
- Conditions
- Cocaine AddictionSubstance AbuseCocaine DependenceCocaine Abuse
- Interventions
- Drug: PlaceboDrug: Huperzine A 0.4 mgDrug: Huperzine A 0.8 mg
- First Posted Date
- 2009-12-11
- Last Posted Date
- 2015-01-27
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 72
- Registration Number
- NCT01030692
- Locations
- 🇺🇸
Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath